In the prostate, low or undetectable levels of AKR1C3 are observed in normal prostate epithelium [18], whereas levels of AKR1C3 expression are significantly elevated in localized [19,20], advanced [21], and recurrent [22] prostate cancer (PCa). The gene discussed is AKR1C3; the disease is posterior cortical atrophy.